These findings indicate that research on GPX4 and its related regulatory mechanisms is gradually deepening from phenotypic description to molecular mechanism analysis, offering unprecedented opportunities for the treatment of breast cancer. This evidence concerns the gene GPX4 and breast carcinoma.